PET microplastics remain in lungs and worsen respiratory tract inflammation

	Allergy
	The latest Allergy news from News Medical

	PET microplastics remain in lungs and worsen respiratory tract inflammation Microplastics (MP) are the subject of intensive medical research, but little is yet known about their effects on the immune system.

	Histamine boost helps the brain remember, decide, and learn from loss Pitolisant, a histamine H3 receptor inverse agonist, improved recognition memory, working memory performance, and reinforcement learning in healthy adults. The findings suggest that histamine helps shape how the brain stabilizes new memories, accumulates evidence for decisions, and avoids overreacting to negative outcomes.

			Review explores diagnosis and management of perioperative anaphylaxis during anesthesia Perioperative anaphylaxis is a rare, life‑threatening condition during anesthesia. The unique setting – multiple drugs, patient draping, and altered physiology – causes higher mortality than anaphylaxis elsewhere.

			How endotoxin-free proteins reduce hidden risks in cancer and immunology research Discover how endotoxin-free proteins help minimize hidden experimental risks in cancer and immunology research.

	Hidden challenges in modern asthma care Many people live with poorly controlled asthma, in fact, 44% of affected children are at risk of severe attacks.

	CIC biomaGUNE develops pulmonary surfactant nanoparticles to treat lung diseases The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that lines the alveoli and enables breathing), which are encapsulated in a drug used to treat pulmonary fibrosis.

	Gladstone receives NIAID grant to establish the Center for PhAIge Therapy When a bacterial infection stops responding to antibiotics, doctors have few options to treat it. Phages-viruses that naturally infect and kill bacteria-have long intrigued clinicians as a potential weapon against these infections.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026